STOCK TITAN

Pharma-Bio Serv, Inc. - PBSV STOCK NEWS

Welcome to our dedicated page for Pharma-Bio Serv news (Ticker: PBSV), a resource for investors and traders seeking the latest updates and insights on Pharma-Bio Serv stock.

PHARM-BIO SERV INC (PBSV) is a leading player in the life sciences industry, specializing in regulatory compliance, validation, and support services for regulated industries. Established in February 1993, PHARM-BIO SERV offers technical services, product and process transfers, commissioning, process engineering, and technology transfer to a variety of industries including pharmaceutical, medical devices, consumer, chemical, and biotechnology sectors in Puerto Rico, the United States, Brazil, and Europe. The company's integrated service structure is designed to provide comprehensive solutions to meet client needs. PHARM-BIO SERV has diversified its services by introducing new divisions to support clients, such as ScienzaLabs, a laboratory testing facility in Puerto Rico and Spain providing microbiological and analytical testing services; Metrologix, offering calibration program management solutions; and Integratek, providing IT services.

Rhea-AI Summary

Pharma-Bio Serv (OTCQB:PBSV), a consulting firm serving various industries including pharmaceuticals, announced a revenue decline for the three and six months ending April 30, 2024. Revenues were $2.4 million and $4.8 million, respectively, marking a decrease of $2.2 million and $4.0 million compared to the same periods last year. The company reported a net loss of $0.2 million and $0.5 million for these periods, compared to net income of $0.4 million and $0.8 million in the previous year. Despite these setbacks, the company is investing in new client relationships and global events to foster growth and stability in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Pharma-Bio Serv, Inc. reported a decrease in revenues for the quarter ended January 31, 2024, with approximately $2.4 million in revenues and a net loss of approximately $270,700. The company aims to achieve sustainable growth and profitability through planned investments in business development infrastructure and resources for fiscal year 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.48%
Tags
none
-
Rhea-AI Summary
Pharma-Bio Serv, Inc. announced a decrease in revenues for the year ended October 31, 2023, but an improvement in net income. The company's overall gross profit improved by 4.6 percentage points compared to last year. The CEO highlighted the strategy of exploiting opportunities in new markets and pursuing robust opportunities in targeted markets to achieve external growth and maximize shareholder value.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-14.95%
Tags
none
Rhea-AI Summary
Pharma-Bio Serv, Inc. (PBSV) announces approval of Special Dividend of $0.075 per share for Shareholders
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.89%
Tags
dividends
-
Rhea-AI Summary
Pharma-Bio Serv reports increase in net income and gross profit margin for Q3 2023. Revenues decrease compared to last year.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.7%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.55%
Tags
dividends
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.24%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none

FAQ

When was PHARM-BIO SERV INC founded?

PHARM-BIO SERV INC was established in February 1993.

What services does PHARM-BIO SERV INC offer?

PHARM-BIO SERV INC provides technical services, product and process transfers, commissioning, process engineering, and technology transfer to various industries.

In which locations does PHARM-BIO SERV INC operate?

PHARM-BIO SERV INC operates in Puerto Rico, the United States, Brazil, and Europe.

What are the divisions created by PHARM-BIO SERV INC to support clients?

PHARM-BIO SERV INC has introduced divisions like ScienzaLabs, a laboratory testing facility, Metrologix for calibration program management solutions, and Integratek for IT services.

What industries does PHARM-BIO SERV INC cater to?

PHARM-BIO SERV INC serves industries including pharmaceutical, medical devices, consumer, chemical, and biotechnology sectors.

What is the core business of PHARM-BIO SERV INC?

PHARM-BIO SERV INC's core business is FDA and international agencies regulatory compliance consulting services.

What is the mission of PHARM-BIO SERV INC?

PHARM-BIO SERV INC aims to provide premium quality and professional consulting services in the markets they serve.

Pharma-Bio Serv, Inc.

OTC:PBSV

PBSV Rankings

PBSV Stock Data

14.88M
8.43M
64.78%
Testing Laboratories
Professional, Scientific, and Technical Services
Link
United States of America
Dorado